CID 76072013

Amredobresib

Structural Information

Molecular Formula
C26H29N9
SMILES
CC1=NN=C2N1C=C(N=C2NC)C3=NC4=C(N3CC5=CC=CC=C5)C=C(C=C4)N6CCN(CC6)C
InChI
InChI=1S/C26H29N9/c1-18-30-31-26-24(27-2)28-22(17-34(18)26)25-29-21-10-9-20(33-13-11-32(3)12-14-33)15-23(21)35(25)16-19-7-5-4-6-8-19/h4-10,15,17H,11-14,16H2,1-3H3,(H,27,28)
InChIKey
JLUUVUUYIXBDCG-UHFFFAOYSA-N
Compound name
6-[1-benzyl-6-(4-methylpiperazin-1-yl)benzimidazol-2-yl]-N,3-dimethyl-[1,2,4]triazolo[4,3-a]pyrazin-8-amine
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

1
References

487
Patents

467.25458 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 468.26186 214.4
[M+Na]+ 490.24380 231.8
[M+NH4]+ 485.28840 219.8
[M+K]+ 506.21774 226.9
[M-H]- 466.24730 220.2
[M+Na-2H]- 488.22925 223.0
[M]+ 467.25403 218.6
[M]- 467.25513 218.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe